Modern treatment of infected total knee arthroplasty with a 2-stage reimplantation protocol

Geoffrey H Westrich1, Sarah Walcott-Sapp, Lindsey J Bornstein

  • 1Department of Orthopedic Surgery, Hospital for Special Surgery, Weill Cornell Medical College, New York, New York 10021, USA.

Insights

Two-stage reimplantation effectively treats infected total knee arthroplasty (TKA), even with multidrug-resistant (MDR) organisms. This protocol eradicates infection in over 90% of cases, offering a reliable solution for TKA complications.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Biomedical Engineering

Background:

  • Total knee arthroplasty (TKA) is a common procedure, but infection remains a significant complication.
  • Managing periprosthetic joint infections (PJIs) after TKA is challenging, particularly with the rise of multidrug-resistant (MDR) pathogens.

Purpose of the Study:

  • To evaluate the efficacy of a two-stage reimplantation protocol for treating infected total knee arthroplasty (TKA).
  • To assess the success rate of this protocol against contemporary pathogens, including multidrug-resistant (MDR) organisms.

Main Methods:

  • Retrospective review of medical records for patients who underwent two-stage reimplantation for infected TKA between April 1998 and March 2006.
  • Infection eradication rates were analyzed, with a minimum follow-up of 2 years.
  • Treatment success was stratified based on the presence of MDR versus non-MDR infecting organisms.

Main Results:

  • The two-stage reimplantation protocol achieved an overall infection eradication rate of 90.7% (68/75 knees).
  • Success rates were comparable for both multidrug-resistant (MDR) infections (91.2%) and non-MDR infections (91.3%).
  • A minimal bactericidal titer of 1:8 was utilized in the treatment protocol.

Conclusions:

  • Two-stage reimplantation remains a highly effective treatment strategy for infected total knee arthroplasty (TKA).
  • The protocol demonstrates significant success in eradicating infections caused by both multidrug-resistant (MDR) and non-MDR pathogens.
  • This supports the continued use of two-stage reimplantation with a 1:8 minimal bactericidal titer for post-TKA infections.